New Zealand markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.15+0.14 (+2.79%)
At close: 04:00PM EDT
5.05 -0.10 (-1.94%)
Pre-market: 08:00AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101010
Avg. Estimate-0.21-0.16-0.61-0.34
Low estimate-0.28-0.32-0.84-0.76
High estimate-0.14-0.06-0.26-0.11
Year ago EPS-0.28-0.4-1.18-0.61
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts991010
Avg. Estimate86.29M98.6M395.69M475.7M
Low estimate84.52M96M382.08M398M
High estimate87.56M101.53M406.75M510.06M
Year ago sales68.78M82.49M331.41M395.69M
Sales growth (year/est)25.50%19.50%19.40%20.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.3-0.23-0.23-0.24
Actual EPS-0.28-0.4-0.19-0.31
Difference0.02-0.170.04-0.07
Surprise %6.70%-73.90%17.40%-29.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.21-0.16-0.61-0.34
7 days ago-0.21-0.16-0.61-0.34
30 days ago-0.22-0.16-0.64-0.35
60 days ago-0.22-0.16-0.72-0.39
90 days ago-0.23-0.19-0.69-0.39
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days5453
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.25.00%N/AN/AN/A
Next qtr.60.00%N/AN/AN/A
Current year48.30%N/AN/AN/A
Next year44.30%N/AN/AN/A
Next 5 years (per annum)44.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A